DavidBrettErasmusMD

Summary

• David Erasmus, MD, MBChB, joined the Department of Medicine at Vanderbilt University Medical Center as faculty in the Division of Allergy, Pulmonary and Critical Care Medicine in 2022. He also serves as medical director of the Vanderbilt Lung Transplant Program.
  
  He completed medical training at the University of Pretoria, South Africa, and subsequently completed a residency in internal medicine and a fellowship in pulmonary and critical care medicine at St. Louis University. Following completion of his fellowship, Dr. Erasmus spent four years in private practice at Unitas Hospital, South Africa, where he practiced pulmonary and critical care medicine with an interest in interventional bronchoscopy. Prior to joining Vanderbilt, he served as Medical Director of the Lung Transplant Program at Mayo Clinic Florida.
  
  Dr. Erasmus has an interest in treatment of large airway complications after lung transplantation and exploring novel diagnostic and therapeutic options for chronic rejection. His clinical interests include ex vivo lung perfusion (EVLP), a new technique that has the potential to increase the supply of donor lungs by rehabilitating organs previously considered too damaged for transplant. His interests also include interventional bronchoscopy after lung transplantation and the use of point-of-care ultrasound in ICU management.
  
  Dr. Erasmus is a member of the American College of Chest Physicians and the International Society for Heart and Lung Transplantation. In addition to his clinical and administrative responsibilities, he is also involved in the education of fellows, medical residents, and medical students.